Literature DB >> 2788124

Suppression of immune responses by dendritic cells infected with HIV.

S E Macatonia1, S Patterson, S C Knight.   

Abstract

Evidence of human immunodeficiency virus (HIV) replication both in the skin Langerhans' cells of AIDS patients (Tschachler et al., 1987) and in normal, peripheral blood dendritic cells (DC) (Patterson & Knight, 1987; Knight & Patterson, 1989) suggests that infection of these antigen-presenting cells may contribute to the immunosuppression seen in AIDS. Support for this hypothesis is now provided by experiments in which the capacity of DC infected in vitro to present mitogen to normal syngeneic lymphocytes was measured. Infecting DC with HIV before culturing with lymphocytes inhibited mitogen-stimulated cell proliferation. Viral DNA was detected in DC in these cultures by in situ hybridization but, in addition, HIV was also present in a small proportion of lymphocytes. However, introducing an inhibitor of virus replication, 2',3' dideoxyadenosine, after infection of the DC but before culturing with lymphocytes, blocked growth of HIV in lymphocytes. In these latter experiments mitogen proliferation responses were still suppressed. Infection of DC could, therefore, cause immunosuppression in AIDS, both by direct effect on antigen-presentation and by the transfer of HIV to T cells.

Entities:  

Mesh:

Year:  1989        PMID: 2788124      PMCID: PMC1385341     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology.

Authors:  S C Knight; J Farrant; A Bryant; A J Edwards; S Burman; A Lever; J Clarke; A D Webster
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

2.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

Review 3.  Lymphoid dendritic cells.

Authors:  J M Austyn
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Epidermal Langerhans cells--a target for HTLV-III/LAV infection.

Authors:  E Tschachler; V Groh; M Popovic; D L Mann; K Konrad; B Safai; L Eron; F diMarzo Veronese; K Wolff; G Stingl
Journal:  J Invest Dermatol       Date:  1987-02       Impact factor: 8.551

5.  Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate.

Authors:  S E Macatonia; A J Edwards; S C Knight
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

6.  Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy.

Authors:  J A Armstrong; R Horne
Journal:  Lancet       Date:  1984-08-18       Impact factor: 79.321

7.  Molecular cloning and characterization of the HTLV-III virus associated with AIDS.

Authors:  B H Hahn; G M Shaw; S K Arya; M Popovic; R C Gallo; F Wong-Staal
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

8.  Overlapping polypeptide induction in human fibroblasts in response to treatment with interferon-alpha, interferon-gamma, interleukin 1 alpha, interleukin 1 beta, and tumor necrosis factor.

Authors:  M H Beresini; M J Lempert; L B Epstein
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

9.  Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus.

Authors:  S Patterson; S C Knight
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

10.  Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.

Authors:  S E Macatonia; S C Knight; A J Edwards; S Griffiths; P Fryer
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

View more
  32 in total

1.  Regulation of primary HIV-1 isolate replication in dendritic cells.

Authors:  T H J MacDougall; R J Shattock; C Madsen; B M Chain; D R Katz
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

2.  The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. I. Spleen dendritic cells.

Authors:  Y Morikawa; M Furotani; K Kuribayashi; N Matsuura; K Kakudo
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

Review 3.  HIV-1 and the hijacking of dendritic cells: a tug of war.

Authors:  Marie Larsson
Journal:  Springer Semin Immunopathol       Date:  2005-01

4.  Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy.

Authors:  M Gompels; S Patterson; M S Roberts; S E Macatonia; A J Pinching; S C Knight
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

5.  Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.

Authors:  A Blauvelt; H Asada; M W Saville; V Klaus-Kovtun; D J Altman; R Yarchoan; S I Katz
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

6.  Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells.

Authors:  Madhavan P N Nair; Zainulabedin M Saiyed; Narayanan Nair; Nimisha H Gandhi; Jose W Rodriguez; Nawal Boukli; Elias Provencio-Vasquez; Robert M Malow; Maria Jose Miguez-Burbano
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-29       Impact factor: 4.147

7.  Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection.

Authors:  Prarthana Beuria; Houchu Chen; Michael Timoney; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

8.  The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells.

Authors:  Johanne Poudrier; Xiaoduan Weng; Denis G Kay; Zaher Hanna; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis.

Authors:  A Ali; S Patterson; K Cruickshank; P Rudge; A G Dalgleish; S C Knight
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

10.  A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.

Authors:  M Clerici; E Roilides; C S Via; P A Pizzo; G M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.